Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation

Exp Hematol. 2005 Oct;33(10):1240-8. doi: 10.1016/j.exphem.2005.06.016.

Abstract

Objective: To compare T-cell reconstitution in two groups of patients submitted to allogeneic stem cell transplantation (SCT): those receiving reduced-intensity conditioning (RIC, n = 24) and those receiving myeloablative conditioning (MA, n = 27).

Methods: Fifty-one consecutive patients undergoing SCT were evaluated. Serial assessments of lymphocyte subsets and T cell receptor excision circles (TRECs) levels were performed using multiparametric flow cytometry and real-time PCR, respectively.

Results: During the first 6 months posttransplant, total and naïve CD4(+) T cell counts were higher after RIC-SCT than after MA-SCT (total CD4(+): p = 0.04, p = 0.08, and p = 0.058; naïve CD4(+): p = 0.14, p = 0.05, and p = 0.01 at 1, 3, and 6 months, respectively). In both groups of patients, TRECs levels were low or undetectable in the first 3 months after SCT and progressively increased during the study. However, a higher proportion of patients with detectable levels of TRECs was observed in RIC-SCT at 1 and 3 months and more patients in this group reached normal levels of TRECs at 6 months post-SCT. In the multivariate analysis, including factors such as type of donor (sibling vs unrelated), dose of CD34(+) cells infused with the graft, patient age, and graft-vs-host disease (GVHD), the most important factor influencing TRECs recovery in the early period after SCT was the type of conditioning regimen.

Conclusions: In this study, the pattern of immune reconstitution after RIC-SCT was different from that of MA-SCT and was characterized by higher posttransplant naïve CD4(+) T cell counts and TRECs levels in the early period after transplant.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antigens, CD34 / immunology
  • CD4 Lymphocyte Count
  • Female
  • Graft vs Host Disease / immunology
  • Humans
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / therapy*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Receptors, Antigen, T-Cell / immunology
  • Recovery of Function / immunology*
  • Stem Cell Transplantation*
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocytes / immunology*
  • Thymus Gland / metabolism*
  • Transplantation Conditioning* / methods
  • Transplantation, Homologous

Substances

  • Antigens, CD34
  • Receptors, Antigen, T-Cell